Why pharma share on radar again today...based on folowing
Reasons... accumulation seen on pharma shares..by large players..
1.indian pharmaceutical industry is expected to export medicines and other goods worth over $25 billion in the current financial year, up from $20.5 billion in 2019-20
2. pharmaceutical exports during the first six months were $11.38 billion, nearly 15 per cent more than that in the same period last year. “This is significant considering that 55 per cent of Indian pharma exports is to highly regulated markets,
3.during this difficult times Indian pharmaceutical industry is doing very well. The world is looking at India for two reasons. One is for generic medicine front, where we are capable of producing quality medicines at affordable prices. Secondly on Covid-19 vaccine front, most of Indian vaccine companies are working closely with academic institutions
4. India is the only country that can produce Covid-19 vaccines in large volumes.
5 .syringes for Covid-19 vaccines. Both the AstraZeneca-Oxford University vaccine produced by Serum Institute of India and Covaxin by Bharat Biotech India Ltd being two-dose vaccines, Indian industry would have to produce 260 crore syringes if the entire Indian population is to be covered.
6. India’s Ayurveda product exports, which are at $3 billion currently, are expected to grow by 16-18 per cent per annum over the next five years.